Soluble complement receptor type 1 (sCR1) in chronic liver diseases

Serum levels at different stages of liver diseases

D. Di Bona, G. Montalto, L. Clemenza, F. Bascone, P. Accardo, D. Bellavia, A. Craxì, M. Brai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Complement receptor type 1 (CR1) is an integral membrane protein of many haematopoietic cells and plays an important role in the clearance of complement-associated immune complexes, favouring their transport to liver and spleen macrophages. A small amount of soluble CR1 (sCR1) is also found in plasma and might originate directly from release of leucocytes and other circulating cells. In previous studies, an increase in serum sCR1 level has been observed in liver cirrhosis and end-stage renal failure. High levels have also been found in patients with some haematologic malignancies. sCR1 serum levels were measured using a specific double sandwich ELISA assay. The present study demonstrates the correlation between mean serum sCR1 concentrations and disease severity in patients with chronic liver disease. In patients with liver cirrhosis, grouped according to the Child-Pugh classification, sCR1 rose as liver function decreased. The presence of neoplastic growth in the liver apparently does not play a role in the increase of sCR1. Serum sCR1 was not elevated in other solid malignancies. Since sCR1 accumulates in liver diseases, evaluation of its serum levels could be useful as a liver function test.

Original languageEnglish
Pages (from-to)102-105
Number of pages4
JournalClinical and Experimental Immunology
Volume114
Issue number1
DOIs
Publication statusPublished - 1998

Fingerprint

Complement Receptors
Liver Diseases
Chronic Disease
Serum
Liver Cirrhosis
Liver
Liver Function Tests
Hematologic Neoplasms
Antigen-Antibody Complex
Chronic Kidney Failure
Membrane Proteins
Leukocytes
Spleen
Enzyme-Linked Immunosorbent Assay
Macrophages

Keywords

  • Child-Pugh
  • Hepatocellular carcinoma
  • Liver disease
  • Soluble CR1

ASJC Scopus subject areas

  • Immunology

Cite this

Soluble complement receptor type 1 (sCR1) in chronic liver diseases : Serum levels at different stages of liver diseases. / Di Bona, D.; Montalto, G.; Clemenza, L.; Bascone, F.; Accardo, P.; Bellavia, D.; Craxì, A.; Brai, M.

In: Clinical and Experimental Immunology, Vol. 114, No. 1, 1998, p. 102-105.

Research output: Contribution to journalArticle

Di Bona, D. ; Montalto, G. ; Clemenza, L. ; Bascone, F. ; Accardo, P. ; Bellavia, D. ; Craxì, A. ; Brai, M. / Soluble complement receptor type 1 (sCR1) in chronic liver diseases : Serum levels at different stages of liver diseases. In: Clinical and Experimental Immunology. 1998 ; Vol. 114, No. 1. pp. 102-105.
@article{1e41bffa479a4bf084280dd5520c3def,
title = "Soluble complement receptor type 1 (sCR1) in chronic liver diseases: Serum levels at different stages of liver diseases",
abstract = "Complement receptor type 1 (CR1) is an integral membrane protein of many haematopoietic cells and plays an important role in the clearance of complement-associated immune complexes, favouring their transport to liver and spleen macrophages. A small amount of soluble CR1 (sCR1) is also found in plasma and might originate directly from release of leucocytes and other circulating cells. In previous studies, an increase in serum sCR1 level has been observed in liver cirrhosis and end-stage renal failure. High levels have also been found in patients with some haematologic malignancies. sCR1 serum levels were measured using a specific double sandwich ELISA assay. The present study demonstrates the correlation between mean serum sCR1 concentrations and disease severity in patients with chronic liver disease. In patients with liver cirrhosis, grouped according to the Child-Pugh classification, sCR1 rose as liver function decreased. The presence of neoplastic growth in the liver apparently does not play a role in the increase of sCR1. Serum sCR1 was not elevated in other solid malignancies. Since sCR1 accumulates in liver diseases, evaluation of its serum levels could be useful as a liver function test.",
keywords = "Child-Pugh, Hepatocellular carcinoma, Liver disease, Soluble CR1",
author = "{Di Bona}, D. and G. Montalto and L. Clemenza and F. Bascone and P. Accardo and D. Bellavia and A. Crax{\`i} and M. Brai",
year = "1998",
doi = "10.1046/j.1365-2249.1998.00707.x",
language = "English",
volume = "114",
pages = "102--105",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Soluble complement receptor type 1 (sCR1) in chronic liver diseases

T2 - Serum levels at different stages of liver diseases

AU - Di Bona, D.

AU - Montalto, G.

AU - Clemenza, L.

AU - Bascone, F.

AU - Accardo, P.

AU - Bellavia, D.

AU - Craxì, A.

AU - Brai, M.

PY - 1998

Y1 - 1998

N2 - Complement receptor type 1 (CR1) is an integral membrane protein of many haematopoietic cells and plays an important role in the clearance of complement-associated immune complexes, favouring their transport to liver and spleen macrophages. A small amount of soluble CR1 (sCR1) is also found in plasma and might originate directly from release of leucocytes and other circulating cells. In previous studies, an increase in serum sCR1 level has been observed in liver cirrhosis and end-stage renal failure. High levels have also been found in patients with some haematologic malignancies. sCR1 serum levels were measured using a specific double sandwich ELISA assay. The present study demonstrates the correlation between mean serum sCR1 concentrations and disease severity in patients with chronic liver disease. In patients with liver cirrhosis, grouped according to the Child-Pugh classification, sCR1 rose as liver function decreased. The presence of neoplastic growth in the liver apparently does not play a role in the increase of sCR1. Serum sCR1 was not elevated in other solid malignancies. Since sCR1 accumulates in liver diseases, evaluation of its serum levels could be useful as a liver function test.

AB - Complement receptor type 1 (CR1) is an integral membrane protein of many haematopoietic cells and plays an important role in the clearance of complement-associated immune complexes, favouring their transport to liver and spleen macrophages. A small amount of soluble CR1 (sCR1) is also found in plasma and might originate directly from release of leucocytes and other circulating cells. In previous studies, an increase in serum sCR1 level has been observed in liver cirrhosis and end-stage renal failure. High levels have also been found in patients with some haematologic malignancies. sCR1 serum levels were measured using a specific double sandwich ELISA assay. The present study demonstrates the correlation between mean serum sCR1 concentrations and disease severity in patients with chronic liver disease. In patients with liver cirrhosis, grouped according to the Child-Pugh classification, sCR1 rose as liver function decreased. The presence of neoplastic growth in the liver apparently does not play a role in the increase of sCR1. Serum sCR1 was not elevated in other solid malignancies. Since sCR1 accumulates in liver diseases, evaluation of its serum levels could be useful as a liver function test.

KW - Child-Pugh

KW - Hepatocellular carcinoma

KW - Liver disease

KW - Soluble CR1

UR - http://www.scopus.com/inward/record.url?scp=0031708725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031708725&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2249.1998.00707.x

DO - 10.1046/j.1365-2249.1998.00707.x

M3 - Article

VL - 114

SP - 102

EP - 105

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -